Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06245356
Title Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer (TRIFLUOX-DP)
Acronym TRIFLUOX-DP
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut du Cancer d'Avignon Avignon 84918 France Details
CHU Jean Minjoz Besançon 25000 France Details
Centre Hospitalier de Cholet Cholet 49300 France Details
Centre Georges François Leclerc Dijon 21079 France Details
Hôpital Privé Jean Mermoz Lyon 69008 France Details
Institut Régional du Cancer de Montpellier - ICM Val d'Aurelle Montpellier 34298 France Details
Hôpital Saint Louis Paris 75010 France Details
Hôpital Saint Antoine Paris 75012 France Details
Hôpital Cochin Paris 75014 France Details
Hôpital des Diaconesses Croix Saint Simon Paris 75960 France Details
CHU de Poitiers Poitiers 86000 France Details
CHU de REIMS Reims 51092 France Details
Institut Godinot Reims 51100 France Details
CH de Saint-Malo Saint-Malo 35403 France Details
Hôpital Nord Franche-Comté / Site du Mittan Trévenans 90400 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field